Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03043144

Taste And Smell TEsting in End Stage Renal Disease

TASTE ESRD: Taste And Smell TEsting in End Stage Renal Disease

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition is an important complication of advanced kidney disease and impairment in smell and taste may affect nutritional status. This study will examine the association between impairment in smell and taste and nutritional and functional markers among patients with end stage renal disease, as well as risk factors for smell and taste impairment.

Detailed description

People with advanced chronic kidney disease (CKD) are at risk for malnutrition, which is associated with significantly increased mortality. Impairments in olfaction and taste are under-recognized and under-addressed symptoms that affect this population. Olfaction and taste influence appetite and nutritional status and represent a unique target for study and intervention. Small cross-sectional studies have shown a higher prevalence of olfactory (up to 56%) and taste disturbances (up to 35%) among patients with CKD compared with the general population, but little is known about longitudinal change in olfaction and taste in this population. Additionally, there is a lack of understanding about why these sensory disturbances more commonly occur in people with CKD, although there is speculation that uremia may contribute. This information gained from this study will address these gaps in knowledge by studying longitudinal changes in olfaction and taste and their associations with concurrent and future nutritional and functional status. Additionally this study will attempt to identify potentially modifiable risk factors associated with olfactory and taste impairment.

Conditions

Interventions

TypeNameDescription
OTHERWorsening of olfaction from enrollment visit to 6 monthsWorsening of olfaction from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes
OTHERWorsening of taste from enrollment visit to 6 monthsWorsening of taste from enrollment visit to 6 months will be evaluated for association with the primary and secondary outcomes
OTHERSerum ZincSerum zinc will be evaluated for association with taste and/or smell impairment
OTHERChronic rhinosinusitisChronic rhinosinusitis will be evaluated for association with smell impairment
OTHERDialysis adequacyDialysis adequacy will be evaluated for association with taste and/or smell impairment
OTHERDecayed missing filled teeth index (DMFT)DMFT will be evaluated for association with taste impairment

Timeline

Start date
2017-02-15
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2017-02-03
Last updated
2017-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03043144. Inclusion in this directory is not an endorsement.